You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 20, 2024

~ Buy the VEKLURY (remdesivir) Drug Profile, 2024 PDF Report in the Report Store ~

List of Excipients in Branded Drug VEKLURY


✉ Email this page to a colleague

« Back to Dashboard


Company Tradename Ingredient NDC Excipient Potential Generic Entry
Gilead Sciences Inc VEKLURY remdesivir 61958-2902 BETADEX SULFOBUTYL ETHER SODIUM 2036-04-29
Gilead Sciences Inc VEKLURY remdesivir 61958-2902 HYDROCHLORIC ACID 2036-04-29
Gilead Sciences Inc VEKLURY remdesivir 61958-2902 SODIUM HYDROXIDE 2036-04-29
Gilead Sciences Inc VEKLURY remdesivir 61958-2902 WATER 2036-04-29
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.